Adaptive Innovations: The AI Bet That Refuses to Be a Software Company
A $60 million wager that the way to fix home health is to stop selling software and become the provider.
For a decade, the playbook for fixing American healthcare was the same: build software, sell it to a hospital or an agency, and hope they actually use it. Adaptive Innovations looked at that playbook and did the opposite. It didn’t build a dashboard for home health agencies. It became one.
That single decision is why this company is worth your attention this week.
Company Overview
In plain English: Adaptive Innovations is a home health care provider that runs on its own AI operating system. When a hospital discharges an elderly patient who needs care at home, a traditional agency handles the intake, scheduling, clinical documentation, and compliance billing through a tangle of legacy software and human coordinators. Adaptive automates that back office with AI and sends its own clinicians into the home. It isn’t selling the tooling to someone else. It’s the licensed provider getting paid to deliver the care.
The company is at the Series A stage. It came out of stealth in early June with $60 million raised to date: a $50 million Series A led by Felicis, plus a previously undisclosed $10 million seed round that Bain Capital Ventures led. The Series A drew in Bain Capital Ventures, Optum Ventures, Sunflower Capital, Conviction, BoxGroup, SV Angel, Dorm Room Fund, and Constellation, along with angels from healthcare services and frontier AI labs.
The founding team runs deep on both sides of the problem. Co-CEOs Alex Wendland and Logan Stinson lead alongside CTO Ryan Tolsma and COO Hunter Stinson, working out of New York City and Dallas. The company says its bench includes engineers from Palantir and Jane Street and operators from McKinsey, Harvard, Stanford, and the U.S. Army Rangers. That’s an unusual mix: people who can ship hard software sitting next to people who’ve actually run operations under pressure.
What have they built so far? According to the company, 200 clinicians have completed more than 100,000 home visits in 18 months. Adaptive reports a rehospitalization rate below 5% against an industry average around 11%, and says its AI workflows have cut clinician documentation time by roughly 80%. Treat those as company-reported figures, because they are. They’re still the kind of early numbers that make sharp investors lean in.
